Literature DB >> 24023453

An in silico approach to design potential siRNA molecules for ICP22 (US1) gene silencing of different strains of human herpes simplex 1.

Suza Mohammad Nur1, Mohammad Al Amin, Rashel Alam, Md Anayet Hasan, Md Amzad Hossain, Adnan Mannan.   

Abstract

BACKGROUND: The herpes simplex virus (HSV-1) is a virus that manifests itself in viral infection with painful, watery blisters in the skin or on the genitals as well as mucous membrane such as the mouth or lips. During an outbreak, the disease is contagious particularly and is irredeemable with present technology. Genetic studies of HSV-1 have shown that ICP22 (US1) gene is an immediate early gene and is responsible for genome replication and also has contribution in viral infection.
METHOD: For disease diagnosis, ICP22 (US1) gene may be suitable target. Viral activity can be controlled through RNA interference technology, a significant method for the post-transcriptional gene silencing. However, in different viral isolates there is a genetic variability; it is very challenging to design possible siRNA molecules which can silence the respective target genes. The work was done by using various computational tools as similarity search, target alignment, secondary structure prediction and RNA interaction evaluation. RESULT: In our study two effective siRNA molecules for ICP22 (US1) gene silencing of seven different strains of HSV-1 were rationally designed and authenticated using computational methods, which might lead to knockdown the viral activity.
CONCLUSION: siRNA molecules were foreseen against ICP22 (US1) gene of different strains of HSV-1 as effective aspirant using computational methods. Thus, the approach may deliver a vision for the chemical synthesis of antiviral RNA molecule for treatment of HSV-1, at genomic level.

Entities:  

Keywords:  Antiviral; HSV-1; ICP22 (US1) gene; RNAi; siRNA

Year:  2013        PMID: 24023453      PMCID: PMC3758079          DOI: 10.1016/j.jyp.2013.05.001

Source DB:  PubMed          Journal:  J Young Pharm        ISSN: 0975-1483


  20 in total

Review 1.  Early shutoff of host protein synthesis in cells infected with herpes simplex viruses.

Authors:  J Matis; M Kúdelová
Journal:  Acta Virol       Date:  2001       Impact factor: 1.162

Review 2.  Peculiarities of herpes simplex virus (HSV) transcription: an overview.

Authors:  Július Rajcáni; Vojvodová Andrea; Rezuchová Ingeborg
Journal:  Virus Genes       Date:  2004-04       Impact factor: 2.332

3.  Use of RNA interference to minimize ischemia reperfusion injury.

Authors:  Zhu-Xu Zhang; Wei-ping Min; Anthony M Jevnikar
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

Review 4.  Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.

Authors:  Aimee L Jackson; Peter S Linsley
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

5.  The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells.

Authors:  Nattika Saengkrit; Phakorn Sanitrum; Noppawan Woramongkolchai; Somsak Saesoo; Nuttaporn Pimpha; Saowaluk Chaleawlert-Umpon; Tewin Tencomnao; Satit Puttipipatkhachorn
Journal:  Carbohydr Polym       Date:  2012-07-06       Impact factor: 9.381

Review 6.  RNAi-based therapeutic strategies for metabolic disease.

Authors:  Michael P Czech; Myriam Aouadi; Gregory J Tesz
Journal:  Nat Rev Endocrinol       Date:  2011-04-19       Impact factor: 43.330

7.  Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B.

Authors:  Ravi P Subramanian; Robert J Geraghty
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

Review 8.  Herpes simplex: insights on pathogenesis and possible vaccines.

Authors:  David M Koelle; Lawrence Corey
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

9.  Design of potential siRNA molecules for T antigen gene silencing of Merkel Cell Polyomavirus.

Authors:  Kazi Muhammad Ahasanul Hoque; Md Faisal Azim; M Robin Mia; Rafidin Kayesh; Md Hazrat Ali; Md Jahidul Islam; Shahriar Kabir Shakil; Tonmay Modak Shuvra
Journal:  Bioinformation       Date:  2012-10-01

10.  A structural interpretation of the effect of GC-content on efficiency of RNA interference.

Authors:  Chi Yu Chan; C Steven Carmack; Dang D Long; Anil Maliyekkel; Yu Shao; Igor B Roninson; Ye Ding
Journal:  BMC Bioinformatics       Date:  2009-01-30       Impact factor: 3.169

View more
  1 in total

1.  Design of Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational Method.

Authors:  Suza Mohammad Nur; Md Anayet Hasan; Mohammad Al Amin; Mehjabeen Hossain; Tahmina Sharmin
Journal:  Interdiscip Sci       Date:  2015-07-30       Impact factor: 2.233

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.